Wednesday, May 22, 2019
Search

SGLT-2 inhibitor - search results

If you're not happy with the results, please do another search

Another Class of Diabetic Drugs to Beware of — Gliptins

One class of potentially dangerous diabetic prescriptions, SGLT-2 inhibitors, have been getting a great deal of attention these days. Meanwhile, a group of medications as gliptins have...

Conflicting Data on Invokana and Kidney Injuries: Manufacturer’s Study Shows “Improved Renal Outcomes,” Independent...

Patients with Type 2 diabetes who take the prescription medication Invokana (canagliflozin) either experience “significantly improved renal outcomes” or risk severe kidney damage –...

Medical Researchers Have Identified a Third Type of Diabetes – Could Certain Prescription Medications...

Medical science has recognized a third form of diabetes – and Medical researchers in the U.K. are concerned that it may be more common...

Johnson & Johnson Moves Ahead in Seeking Approval For Expanded Use of Invokana

Despite the demonstrated links between lower limb amputations, kidney failure, osteoporosis and acute pancreatitis, Johnson & Johnson has followed through with its earlier plans...

Invokana Maker Turned Health Care Consumers into Guinea Pigs

If you were fully informed about the potential side effects of a medication, would you still choose to take it? This is the cause of...

Invokana: The “Cure” That is as Bad As The Disease

Initially hailed as a “miracle drug” in the treatment of Type 2 diabetes, Invokana is part of a class of drugs known as “gliflozins.”...

As the Nation Struggles With an Addiction Epidemic, the FDA Approves a New Opioid-Based...

Just before the weekend, the U.S. Food and Drug Administration gave its approval for a new, powerful and fast-acting opioid medication, despite serious concerns...

The Proof Is In: Invokana Puts Diabetic Patients at Greater Risk for Amputation

Last year, the European Medicines Agency (EMA) started an investigation into the possibility that use of the diabetic medication Invokana (canagliflozin) increased a patient's...

Invokana and Amputation Risk: E.U. Health Authorities Now Require Package Warning

Last year (May 2016), the U.S. Food and Drug Administration issued an “advisory” to physicians regarding results of a continuing clinical trial indicating that...